Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Docetaxel|DRUG: Doxorubicin|DRUG: Carboplatin|DRUG: Cyclophosphamide|DRUG: Trastuzumab|DRUG: Bevacizumab
Sponsor: Sanofi